CLS Holdings USA, which operates as Cannabis Life Sciences, last week announced a strategic partnership with Soma, which specializes in solventless cannabis extraction technologies, to introduce a new solventless cannabis vape product to the Nevada market.
The upcoming solventless cannabis vape product is expected to deliver the pure essence of cannabis without the use of solvents in the extraction process. Using Soma's proprietary extraction technology and process, the new vape line will offer consumers a potent, flavorful, cleaner and more authentic cannabis experience, according to the companies.
According to Joseph Ramalho, COO of CLS Holdings, Soma's proprietary extraction methods should help establish new standards for purity and quality in the cannabis industry.
Christopher Pagels, CEO of SOMA, says his company will lean on CLS' expertise in product development and distribution.
The solventless cannabis vape is expected to launch before April 20, 2024.
